HIV Neutralisation Assay

The following paper describes how InPheno adapted its HIV neutralisation assay in order to offer the solution for the low supply of biological samples for its evaluation of vaccine efficacy in humans during clinical trials. This adaptation of HIV neutralisation assay allowed InPheno to assess the presence of HIV neutralising antibodies in vaccines.

To read the full article please click on the link below:
HIV Neutralisation Assay